StockData
ARS Pharmaceuticals, Inc. logo

ARS Pharmaceuticals, Inc. (SPRY) income statement

SPRYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$2.96−0.40 (-11.90%)

Close on Nov 20, 2026Market cap $294.36MP/E –Yield –

See a number that looks wrong?